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Abstract
Cancer and stem cells appear to share a common metabolic profile that is characterized by high 
utilization of glucose through aerobic glycolysis. In the presence of sufficient nutrients, this 
metabolic strategy provides sufficient cellular ATP while additionally providing important 
metabolites necessary for the biosynthetic demands of continuous cell proliferation. Recent studies 
indicate that this metabolic profile is dependent on genes that regulate the fusion and fission of 
mitochondria. High levels of mitochondrial fission activity are associated with high proliferation 
and invasiveness in some cancer cells and with self-renewal and resistance to differentiation in 
some stem cells. These observations reveal new ways in which mitochondria regulate cell 
physiology, through their effects on metabolism and cell signaling.
Introduction
Depending on the cell type, a mammalian cell can have several to thousands of 
mitochondria. In metabolically active cells, such as hepatocytes and cardiomyocytes, the 
mitochondria make up 20–30% of the cell volume. These mitochondria do not operate as 
isolated organelles; rather, they function as a collective whose activity is orchestrated by 
mitochondrial dynamics. The identities of individual mitochondria are constantly altered by 
continuous cycles of membrane fusion and fission, which serve to mix the contents of the 
mitochondrial population, promote homogeneity of the organelles, control the morphology 
of mitochondria, and maintain their high functionality. The term "mitochondrial dynamics" 
has come to encompass additional behaviors of mitochondria, such as their transport along 
the cytoskeleton, their selective degradation by the mitophagy pathway, and their 
interactions with other organelles, including the endoplasmic reticulum. This review focuses 
on the role of fusion/fission dynamics in the biology of cancer and stem cells.
Mitochondria play central roles in determining the physiology, and particularly the 
metabolism, of most eukaryotic cells. Cell physiology, in turn, is critically important in 
regulating the proliferative and developmental potential of cells. Given this, it is perhaps not 
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surprising that bidirectional links have been uncovered between mitochondrial dynamics and 
cell replication. We introduce the fundamentals of mitochondrial fusion and fission, and then 
discuss the effect of mitochondrial dynamics in cell cycle control and how interruption of 
this control can contribute to tumorigenesis. We then describe emerging evidence that the 
distinct metabolism of tumor cells is regulated by mitochondrial dynamics, along with the 
striking parallels in regenerating stem cells. Apoptotic pathways also play important roles in 
cancer biology and are regulated by mitochondrial dynamics, but are beyond the scope of 
this review and have been extensively discussed elsewhere (Sheridan and Martin, 2010; Suen 
et al., 2008).
Mitochondrial fusion and fission
Fusion and fission are opposing processes that must be balanced to enable efficient content 
exchange between mitochondria while maintaining the proper mitochondrial morphology 
(Chan, 2012; Labbe et al., 2014). Although the machineries for fusion and fission are 
distinct, there is evidence that fission events are temporally coordinated with fusion events 
(Twig et al., 2008), a collaboration that helps to keep the two processes balanced. Severe 
defects in either mitochondrial fusion or fission lead to mitochondrial dysfunction. In part, 
this dysfunction occurs because the processes become unbalanced, and cell physiology can 
be restored by manipulating mitochondrial dynamics to obtain a new, re-balanced setpoint 
(Bleazard et al., 1999; Chen et al., 2015; Sesaki and Jensen, 1999).
Because mitochondria are double-membraned organelles, mitochondrial fusion involves 
outer membrane fusion followed by inner membrane fusion (Chan, 2012; Labbe et al., 
2014). The net result is the coordinated merger of four lipid bilayers and the formation of a 
single, fused mitochondrial matrix (the compartment encased by the inner membrane). 
These two membrane fusion events are normally coupled in vivo but can be uncoupled in 
vitro, because they have distinct requirements for co-factors and metabolism. Outer 
membrane fusion is mediated by mitofusins, large GTPases of the dynamin family that are 
embedded on the mitochondrial outer membrane. Mammals have two mitofusins termed 
MFN1 (Mitofusin 1) and MFN2 (Mitofusin 2). In the absence of MFN1 and MFN2, 
mitochondria fail to fuse their outer membranes, either in live cells or in biochemically 
isolated organelles. Following outer membrane fusion, OPA1 (Optic Atrophy 1), another 
dynamin family member, mediates inner membrane fusion. Cells lacking OPA1 show outer 
membrane fusion intermediates that cannot progress to full fusion and that ultimately 
resolve by fission.
Disruption of mitochondrial fusion genes lead to neurodegenerative disease (Carelli and 
Chan, 2014). Charcot-Marie-Tooth type 2A, an axonopathy of long peripheral nerves, is 
caused by autosomal dominant mutations in MFN2. Similarly, autosomal dominant 
mutations in OPA1 are the predominant cause of dominant optic atrophy, a disease of the 
optic nerve that results in reduced visual acuity or blindness. In both these diseases, the 
heterozygous mutations result in mild reductions in mitochondrial fusion that are compatible 
with development into adulthood but lead to defects in specific neurons. In contrast, when 
homozygous null alleles are constructed in mouse models, they result in severe embryonic 
and neuromuscular phenotypes (Chen et al., 2003; Chen et al., 2007; Chen et al., 2010).
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The central player in mitochondrial fission is DRP1 (Dynamin-related protein 1), a large 
GTPase (Chan, 2012; Labbe et al., 2014) (Figure 1). A pool of DRP1 resides in the cytosol 
and must be recruited to the mitochondrial surface to mediate fission. Once on the 
mitochondrial surface, DRP1 functions as a mechano-chemical enzyme that forms helical 
assemblies that constrict the mitochondrial tubule. Its mechanism of action is conceptually 
analogous to the role of classical dynamins in constricting the necks of endocytic vesicles at 
the cell surface (Ferguson and De Camilli, 2012; Schmid and Frolov, 2011). Recent results, 
however, suggest that the mechanical properties of Dp1 may be insufficient to complete the 
scission process (Lee et al., 2016). When DYN2 (Dynamin 2) is depleted, mitochondrial 
tubules with narrow constrictions accumulate. The accumulation of these apparent fission 
intermediates suggests that whereas DRP1 constricts mitochondrial tubules, this 
compression is not sufficient to complete fission, and that DYN2 instead may be additionally 
required at the final step of scission.
Mitochondrial fission begins with interaction of mitochondria with the endoplasmic 
reticulum, which causes initial constriction of the mitochondrial tubule (Figure 1) (Friedman 
et al., 2011). DRP1 is subsequently recruited to the mitochondrial surface through 
association with several DRP1 receptors embedded in the outer membrane. One important 
DRP1 receptor is MFF (mitochondrial fission factor), whose depletion leads to dramatic 
mitochondrial elongation (Gandre-Babbe and van der Bliek, 2008) and reduction of DRP1 
on mitochondria (Loson et al., 2013; Otera et al., 2010). Two other proteins, MID49 
(mitochondrial dynamics protein of 49 kDa) and MID51 (mitochondrial dynamics protein of 
51 kDa), also play significant roles in recruiting DRP1 (Loson et al., 2013; Otera et al., 
2016; Palmer et al., 2013). FIS1 (Fission 1) was initially identified as the first DRP1 
receptor, based on its clear involvement in mitochondrial fission in budding yeast. However, 
FIS1 appears to have little, if any, role in mitochondrial fission in mammalian cells (Loson et 
al., 2013; Otera et al., 2010). More recent work has implicated FIS1 in the degradation of 
dysfunctional mitochondria (Rojansky et al., 2016; Shen et al., 2014; Yamano et al., 2014).
As with mitochondrial fusion, loss of mitochondrial fission results in human disease. 
Mutations in DRP1 result in clinical phenotypes with a strong neurological component, 
ranging from microcephaly with multi-organ failure and neonatal lethality to intractable 
epilepsy in childhood (Fahrner et al., 2016; Nasca et al., 2016; Sheffer et al., 2016; Vanstone 
et al., 2016; Waterham et al., 2007; Yoon et al., 2016). Homozygous mutations in MFF result 
in severe neuromuscular disease (Koch et al., 2016; Shamseldin et al., 2012). The severe 
phenotypes of mouse DRP1 or MFF knockouts also point to the critical role of 
mitochondrial fission in tissue physiology (Chen et al., 2015; Ishihara et al., 2009; 
Wakabayashi et al., 2009). Interestingly, loss of either fusion or fission can lead to 
mitochondrial DNA (mtDNA) instability, which may exacerbate pathological phenotypes 
(Amati-Bonneau et al., 2008; Chen et al., 2007; Chen et al., 2010; Ishihara et al., 2009; 
Parone et al., 2008).
Mitochondrial dynamics during the cell cycle
It has been known for many decades that mitochondria are symmetrically partitioned to 
daughter cells during a typical cell division (Christiansen, 1949). Detailed imaging studies of 
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cultured cells indicate that mitochondrial morphology undergoes stereotyped changes during 
progression through the cell cycle (Margineantu et al., 2002; Mitra et al., 2009; Taguchi et 
al., 2007). The two most apparent features are tubulation of the mitochondria network at the 
G1/S transition and extensive fragmentation during mitosis (Figure 2). The elongated, 
"hyperfused" network at G1/S is associated with higher ATP production and affects entry 
into S phase by controlling the levels of cyclin E (Mitra et al., 2009). Extensive 
fragmentation during mitosis likely increases the likelihood of equitable inheritance of 
mitochondria to daughter cells, because partitioning is thought to occur passively during 
cytokinesis. Nevertheless, cells lacking DRP1 are capable of undergoing cell division, even 
though they maintain filamentous mitochondria throughout the cell cycle (Ishihara et al., 
2009; Taguchi et al., 2007). Daughter cells arising from DRP1-deficient cells do inherit 
mitochondria, suggesting that the cytokinesis machinery is capable of dividing mitochondria 
in a DRP1-independent manner; however, the partitioning of mitochondria to daughter cells 
appears less equitable (Ishihara et al., 2009). Although mitochondrial inheritance during cell 
division in most animal cells has been assumed to be passive, it should be noted that budding 
yeast has active mechanisms to transport a subset of mitochondria into the daughter cell and 
retain others in the mother cell (Vevea et al., 2014; Westermann, 2014). In addition, stem-
like cells from the mammary gland display DRP1-dependent, asymmetric inheritance of 
mitochondria, suggesting that, even in mammalian cells, not all mitochondrial segregation is 
passive (Katajisto et al., 2015).
DRP1 plays a crucial role in controlling cell-cycle-associated changes in mitochondrial 
morphology (Figure 2). Phosphorylation of a conserved serine (S616 in human DRP1 
variant 1) by the mitotic kinase CDK1/cyclin B causes fragmentation of the mitochondrial 
network early in M phase (Taguchi et al., 2007). This phosphorylation is accompanied by an 
MFF-dependent rise in DRP1 levels on the mitochondrial surface (Kashatus et al., 2011). 
Aurora A, a mitotic kinase, works upstream to direct the activity of CDK1/cyclin B onto 
DRP1. Aurora A phosphorylates RALA, a RAS-like GTPase. Phosphorylated RALA is 
released from the plasma membrane and concentrates, along with its effector protein 
RALBP1, at the mitochondrial surface. RALBP1 associates with CDK1/cyclin B and 
activates its kinase activity, leading to DRP1 phosphorylation at position 616 (Kashatus et 
al., 2011). Loss of either RALA or RALBP1 disrupts mitotic mitochondrial fission and 
results in decreased cell proliferation. Underscoring the importance of DRP1 in mitotic 
progression, inhibition of DRP1 results in delayed S-phase entry (Mitra et al., 2009) and 
partial G2/M arrest (Qian et al., 2012).
Another level of control for DRP1 during the cell cycle resides in its alternative splicing of 
three exons (Strack et al., 2013). Splice variants which contain the third alternative exon 
without the second one bind to microtubules, thus sequestering DRP1 away from 
mitochondria. Interestingly, this association is only found with highly bundled microtubules, 
as depolymerization by nocodazole removes DRP1 from α-tubulin and increases DRP1-
mitochondria interactions. Phosphorylation of DRP1-S616 by CDK1 promotes dissociation 
of the DRP1 from microtubules, increases DRP1 levels on mitochondria, and thereby 
augments mitochondrial fragmentation.
Chen and Chan Page 4
Cell Metab. Author manuscript; available in PMC 2018 July 05.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
DRP1 also demonstrates strong interactions with another cell cycle protein, cyclin E. 
Although it is unclear how this interaction regulates normal cell cycle progression, it is 
evident that inhibition of DRP1 leads to increased levels of cyclin E throughout the cell 
cycle, and especially during the G2/M transition (Mitra et al., 2009; Parker et al., 2015; Qian 
et al., 2012). This cyclin E buildup causes replication stress in the form of premature entry 
into a prolonged S-phase, chromosomal instability, and subsequent aneuploidy. Some stem 
cells demonstrate a similar profile of enhanced cyclin E, short G1, and long S-phase, and 
indeed, progenitor cell markers are upregulated in DRP1-inhibited cells (Parker et al., 2015). 
Interestingly, concurrent knockdown of the mitochondrial fusion protein, OPA1, with DRP1 
abrogates the elevation of cyclin E levels (Qian et al., 2012), suggesting it may be the 
hyperfused mitochondrial morphology of DRP1-inhibited cells that causes increased cyclin 
E levels. It is as yet unclear how mitochondrial morphology controls cyclin E, but 
intriguingly, a mitochondrial pool of cyclin E, which is not phosphorylated and degraded as 
the nuclear pool is, was discovered recently (Parker et al., 2015).
DRP1 is also regulated by phosphorylation at S637. A number of kinases and phosphatases 
act on this site, including protein kinase A (PKA), calcium/calmodulin-dependent protein 
kinase 1α (CaMK1α), calcineurin, and protein phosphatase 2A (PP2A) (Chang and 
Blackstone, 2010). Most studies have found phosphorylation at S637 to inhibit the fission 
activity of DRP1. Although there is no evidence demonstrating involvement of S637 
phosphorylation during normal cell cycle progression, several cancer studies suggest that 
increased tumorigenesis correlates with decreased S637 phosphorylation, as described below 
(Rehman et al., 2012; Xie et al., 2015).
Enhanced mitochondrial fission in cancer cells
Cancer progression consists of tumorigenesis, during which cells multiply in an unrestrained 
manner, and subsequent cell invasion, which allows metastatic spread of tumor cells to other 
tissues and organs. Biochemical pathways present in normal cells are often co-opted in 
tumor cells to promote their growth. Cell cycle pathways are prime targets, and given the 
prominent effect of DRP1 on cell cycle, it is perhaps unsurprising that DRP1 seems to be 
activated in several cancer types.
In a survey of several lung cancer cell lines, the mitochondria were found to be highly 
fragmented, when compared to unrelated primary cells obtained from the lung (Rehman et 
al., 2012). In multiple cultured lung adenocarcinoma cell lines and human patient samples, 
mitochondrial fragmentation is correlated with reduced levels of MFN2 and higher levels of 
DRP1. In addition, there is more abundant phosphorylation of the activating S616 site and 
less phosphorylation of the inactivating S637 site. When MFN2 is overexpressed or DRP1 is 
inhibited, tumor growth is reduced in vitro and in vivo. This growth reduction involves both 
reduced proliferation and increased apoptosis. Therefore, as in normal cell cycle, increased 
fission/decreased fusion seems to push these cancer cells into mitosis, thus increasing cell 
replication.
Similarly, a specific pathway for increasing DRP1-mediated mitochondrial fission has been 
uncovered in RAS-induced tumors (Kashatus et al., 2015; Serasinghe et al., 2015) (Figure 
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1). In cultured cells transformed by the oncogenic RASG12V mutant, mitochondria are 
fragmented due to increased activity of DRP1. DRP1 is activated by phosphorylation of 
S616 by the MAP kinases ERK1 and ERK2. Importantly, inhibition of this pathway reduces 
the proliferation of RASG12V transformed cells and their ability to generate tumors in a 
xenograft model. These results indicate that the MAP kinase pathway can regulate 
mitochondrial fission to remodel mitochondria during cell transformation. Whereas DRP1 
activation by CDK1 phosphorylation is specific to mitosis, in cancer cells, ERK1/2 
activation of DRP1 leads to fragmented mitochondria throughout the cell cycle.
There is increasing evidence that tumors often contain a subpopulation of cells with 
enhanced capacity to initiate new tumors when transplanted to a novel site. Such tumor-
initiating cells have been termed cancer stem cells, and they share some parallels with 
normal stem cells that function during development, in that they can undergo both self-
renewal and differentiation (Pattabiraman and Weinberg, 2014; Zhou et al., 2009). A recent 
study suggests that brain tumor initiating cells (BTICs) have a distinct mitochondrial profile, 
compared to non-initiating tumor cells, that is driven by mitochondrial fission (Xie et al., 
2015). In surgical samples of glioblastomas, the initiating cell subpopulation (isolated by 
cell surface markers) has elevated levels of DRP1-S616 phosphorylation due to the activity 
of CDK5, and downregulated levels of inhibitory DRP1-S637 phosphorylation. Inhibition of 
DRP1 activity hinders growth of the initiating cells in culture and in xenografts. Importantly, 
the level of DRP1-S616 phosphorylation negatively correlates with glioblastoma patient 
survival.
Of note, the opposing force of mitochondrial fusion seems to slow growth of several cancer 
lines. As described above, MFN2 overexpression can reduce lung cancer growth (Rehman et 
al., 2012; Xie et al., 2015). In another example, mouse medulloblastoma cells and tumors 
express lower levels of MFN1/2 as compared to non-transformed cells (Malhotra et al., 
2016). Medulloblastoma is the most common malignant brain tumor found in children. 
Upon mitofusin overexpression, cell proliferation, as measured by BrdU labeling and cyclin 
D2 levels, is decreased.
Cancer cell migration
During progression to a metastatic phenotype, cancer cells undergo an epithelial-to-
mesenchymal transition and acquire greater mobility and invasiveness. These qualities are 
required for cancer cells to invade surrounding tissue, enter the bloodstream, migrate 
throughout the body and seed additional organs. Once again, mitochondrial fragmentation 
has been found to increase in malignant cells and to promote tumor cell invasion. As 
compared to non-metastatic breast tumors, invasive breast carcinomas and metastases 
express higher levels of DRP1 and lower levels of MFN1 (Zhao et al., 2013). Using in vitro 
transwell cell invasion assays with metastatic and non-metastatic breast cancer cell lines, 
inhibition of DRP1 activity or overexpression of MFN1/2 greatly reduces cell migration and 
invasion, whereas silencing of mitofusins increases invasive activity. Enhanced migration is 
accompanied by more lamellipodia formation and mitochondrial accumulation in the 
lamellipodia periphery. Mitochondrial respiration is required for this process, presumably 
due to the high energy demands of F-actin polymerization, a central step in formation of 
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lamellipodia. Similar patterns were found in malignant, oncoctyic thyroid carcinomas 
(Ferreira-da-Silva et al., 2015). A sampling of human tumors found increased DRP1 
expression in malignant cells. Furthermore, either mdivi-1, a chemical inhibitor of DRP1 
(Cassidy-Stone et al., 2008), or dominant-negative DRP1 can inhibit migration and invasion 
of thyroid cancer cell lines in scratch-wound assays and transwell experiments.
Mechanistically, NF-κB-inducing kinase (NIK) seems to regulate DRP1 involvement in cell 
migration in multiple cancer types, including glioma, breast cancer, and pancreatic cancer 
(Jung et al., 2016). Loss of NIK greatly reduces invasive activity and causes congregation of 
mitochondria around the nucleus as opposed to their normal, predominantly anterograde 
movement toward the leading edge of migrating cancer cells. NIK is localized to the 
mitochondria, recruits DRP1, and promotes (perhaps indirectly) phosphorylation of DRP1-
S616 and dephosphorylation of DRP1-S637, thus increasing mitochondrial fission. DRP1 
seems to act downstream of NIK as deletion of DRP1 abrogates NIK-dependent 
invasiveness.
As for cell growth, mitochondrial fusion seems to oppose fission and inhibits invasiveness of 
both breast and lung cancers (Xu et al., 2017). Low expression of MFN2 for patients of both 
diseases correlates with poor prognosis. In vitro transwell assays and in vivo xenograft 
metastasis experiments demonstrate that MFN2 loss in cancer cell lines stimulate cell 
migration. Biochemically, MFN2 binds directly to Rictor in the mammalian target of 
rapamycin complex 2 (mTORC2) and suppresses AKT signaling.
Reactive oxygen species (ROS) in cancer
While a comprehensive examination of the role of ROS in cancer is beyond the scope of this 
review, it must be mentioned that cancer cells often contain increased levels of ROS, which 
are mostly generated by the mitochondria (Panieri and Santoro, 2016; Sullivan and Chandel, 
2014). ROS promote tumor growth by altering cellular metabolism and acting as signaling 
molecules in growth factor pathways. Interestingly, ROS can also affect expression and post-
translational modifications of mitochondrial dynamic proteins, which may further stimulate 
tumorigenesis (Willems et al., 2015). Heteroplasmic mtDNA mutation levels correlate with 
ROS production, tumorigenicity, and metastastic potential (Sullivan and Chandel, 2014). 
Given the importance of mitochondrial dynamics in maintaining mtDNA stability and ROS 
levels (Amati-Bonneau et al., 2008; Chen et al., 2007; Chen et al., 2010; Chen et al., 2015; 
Ishihara et al., 2009; Parone et al., 2008), it is likely that mitochondrial fusion and fission 
impinge on cancer dynamics at least partially through ROS activity.
Parallels between the mitochondrial and metabolic profiles of cancer cells 
and stem cells
Cancer cells are known to have distinct metabolic profiles compared to their normal 
counterparts. Many cancer cells display the Warburg effect, in which cells predominantly 
rely on glycolysis over oxidative phosphorylation (OXPHOS), even when oxygen is plentiful 
(Pavlova and Thompson, 2016; Vander Heiden et al., 2009). In the clinical setting, this 
prominent property has been exploited in the use of positron emission tomography to image 
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some tumors based on their high uptake of positron-emitting glucose analogs. Cancer cells 
displaying the Warburg effect use predominantly glycolysis over OXPHOS, even though 
they generally have functional mitochondria (Figure 3). Given that glycolysis is far less 
efficient than OXPHOS at extracting energy from glucose, generating only 2 ATP instead of 
36 ATP, why would rapidly reproducing cells undergo metabolic reprogramming to 
preferentially utilize glycolysis? The prevailing hypothesis is that in the presence of ample 
nutrients, high glycolytic flux generates sufficient cellular energy while providing the 
building blocks for cell growth, such as acetyl-CoA for fatty acids, glycolytic intermediates 
for amino acids, and ribose for nucleotides (Figure 3). In addition, there is evidence that 
lactate produced by glycolytic tumor cells is not merely a waste product but can be used to 
“feed” adjacent oxidative cancer cells and/or to signal vascular endothelial cells to initiate 
angiogenesis (Doherty and Cleveland, 2013; Sonveaux et al., 2008). The latter point 
emphasizes that cancer cells are notoriously heterogeneous, and that the Warburg effect is 
not a feature of all types of cancers, or even of all cancer cells in a given tumor.
Given the similarities between stem cells and aggressive cancer cells in terms of replicative 
needs and non-differentiated status, it is quite interesting that recent studies reveal that stem 
cells have a metabolic profile reminiscent of that of cancer cells. Stem cells rely primarily on 
“aerobic glycolysis” to generate energy. This is defined as preferential utilization of 
glycolysis over OXPHOS even in an environment rich with oxygen. Pluripotent embryonic 
stem cells (ESCs) and induced pluripotent cells (iPSCs)--which are generated by 
reprogramming of adult, differentiated cells by expression of the Yamanaka factors (OCT4, 
SOX2, KLF4 and c-MYC)--have high glycolytic flux and relatively low mitochondrial 
respiration (Kondoh et al., 2007; Prigione et al., 2010; Zhang et al., 2011). Mitochondria in 
these cells are generally characterized as sparse and “immature,” containing less mtDNA 
and demonstrating underdeveloped cristae structure. Upon differentiation to terminal cell 
types, mitochondrial content and utilization of OXPHOS are typically increased (Figure 4). 
For example, human ESC lines have sparse mitochondria, but during differentiation into 
cardiomyocytes, they accumulate mitochondria and turn from glycolysis to fatty acid 
oxidation as their primary source of energy (St John et al., 2005). It should be noted that 
these differences in mitochondrial mass may be exaggerated due to the small size of 
pluripotent cells. One study found that the differences in mitochondrial mass between 
human iPSCs and ESCs compared to fibroblasts are minimal when normalized to total 
protein content (Zhang et al., 2011).
Several reasons have been proposed for why it may be beneficial for ESCs versus 
differentiated cells to favor a higher glycolysis:OXPHOS ratio for energy production (Zhang 
et al., 2012). First, in the presence of ample glucose and other nutrients, glycolysis provides 
sufficient cellular ATP while reducing the production of reactive oxygen species (ROS) that 
are a normal byproduct of cellular respiration. Stem cells are a long-term source for cellular 
regeneration, and therefore longevity and genome maintenance are priorities. Containment 
of ROS may be important for longevity by minimizing ROS-induced telomere shortening 
and for genome integrity by reducing DNA and protein damage. Second, as for cancer cells, 
glycolytic metabolism can be regulated to yield important chemical building blocks that are 
critical for synthesis of amino acids, lipids, and nucleic acids, which are important for cells 
that continually replicate and divide (Figure 3). For example, shunting of glycolytic 
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intermediates into the pentose phosphate pathway generates ribose-5-phosphate, a precursor 
for nucleotide synthesis, and NADPH, which provides reducing power to drive nucleotide 
and lipid biosynthesis. Moreover, under oxidative stress conditions, mouse ESCs 
additionally depend on NADPH from the pentose phosphate pathway for detoxification of 
reactive oxygen species (Filosa et al., 2003). Finally, cytosolic acetyl-CoA, derived from 
glycolytically produced pyruvate, is critical to maintain histone acetylation and thus, 
pluripotency (Moussaieff et al., 2015). Therefore, stem cells and differentiated cells have 
distinct metabolic profiles that are tailored to their divergent cellular needs and functions. It 
should be noted that whereas cancer cells and stem cells both favor glycolysis over 
OXPHOS, the usage of downstream effectors, such as lactate and acetyl-CoA, may differ 
greatly (Shyh-Chang and Daley, 2015).
The likely functional importance of these metabolic profiles is highlighted by the 
observation that reprogramming of somatic cells to iPSCs is associated with downregulation 
of respiratory chain activity and increased glycolysis (Folmes et al., 2011; Zhu et al., 2010). 
Whereas mouse embryonic fibroblasts have organized mitochondrial networks displaying 
ample cristae, the iPSCs derived from them have few and "regressed" mitochondria with 
sparse cristae, morphological features suggesting reduced mitochondrial activity (Zhu et al., 
2010). Glucose utilization increases, along with lactate production and its efflux from the 
cell. Drugs that inhibit glycolysis, such as deoxyglucose, substantially reduce the efficiency 
of reprogramming, whereas glucose supplementation or stimulation of glycolysis has the 
opposite effect.
Moreover, there is evidence that mitochondrial changes occur prior to the acquisition of 
pluripotential markers. In mouse embryonic fibroblasts (MEFs) that are undergoing 
reprogramming, mitochondrial membrane potential and expression of glycolytic gene 
expression are increased well before the pluripotential state is achieved (Folmes et al., 2011). 
Consistent with this, during differentiation of human pluripotent stem cells, a metabolic shift 
from glycolysis towards oxidative phosphorylation occurs prior to the loss of pluripotency 
markers, such as OCT4 (Zhang et al., 2011). These temporal correlations suggest that 
remodeling of mitochondrial activity may be important in determining cell state. Given the 
striking changes in mitochondrial architecture that occur when stem cells differentiate and 
when somatic cells are reprogrammed, it is reasonable to ask what role mitochondrial 
dynamics might play. Furthermore, the parallels between cancer cells and stem cells in terms 
of metabolism and rapid division argue that common mechanisms may govern the 
biochemical changes in stem cells and cancer cells.
Mitochondrial dynamics in stem cells
Mitochondrial fission driven by DRP1 seems to play a crucial role in developing and 
maintaining pluripotency. Mdivi-1, a chemical inhibitor of DRP1, inhibits the transition of 
MEFs into iPSC colonies when applied early in reprogramming (Vazquez-Martin et al., 
2012). This compound is now known to have off-target effects (Bordt et al., 2017), including 
inhibition of respiratory Complex I, so such experiments need to be re-evaluated. 
Nevertheless, downregulation of DRP1 function by other means--RNAi and overexpression 
of a dominant negative DRP1--greatly diminishes the re-programming efficiency of 
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fibroblasts, as measured by the formation of colonies positive for alkaline phosphatase, a 
marker of pluripotency (Prieto et al., 2016b). During the reprogramming process, DRP1 is 
activated by phosphorylation of S616 by ERK1/2. This phosphorylation is maintained 
partially by downregulation of DUSP6, a MAPK phosphatase. However, the changes in 
mitochondrial dynamics during reprogramming are complex, with mitochondria undergoing 
severe fragmentation during the early phase of reprogramming, followed by restoration to 
shorter tubules when pluripotent colonies are formed (Prieto et al., 2016b).
During MEF reprogramming, mitochondrial fission appears to depend primarily on DRP1, 
MID51 and GDAP1 (Prieto et al., 2016a). MID51 is one of several mitochondrial outer 
membrane receptors for DRP1. GDAP1 is a mitochondrial outer membrane protein that is 
involved in some forms of Charcot-Marie-Tooth disease and regulates mitochondrial fission, 
but its mechanism of action remains unclear (Niemann et al., 2005). In addition, there is 
evidence for a moderate role for MFF, but no role for FIS1 and MID49. GDAP1 knockout 
MEFs form only 25% of the number of alkaline-phosphatase-positive colonies upon 
reprogramming when compared to control MEFs. Interestingly, a G2/M block seems to 
occur in GDAP1-null cells (Prieto et al., 2016a), similar to that found during DRP1 
inhibition (Qian et al., 2012).
Even in naturally pluripotent human ESCs (hESCs), maintenance of pluripotency is 
dependent on DRP1 activity (Son et al., 2013). REX1, a transcriptional activator of cyclins 
B1 and B2, promotes DRP1-S616 phosphorylation, mitochondrial fragmentation, and 
increased glycolytic activity. In stable knockdowns of REX1, hESC cells lose proliferative 
capacity and partially arrest at the G2/M transition of the cell cycle. The REX1-deficient 
ESCs differentiate at a higher rate and have defects in embryoid body and teratoma 
formation. Knockdown of DRP1 also promotes hESC differentiation, whereas 
overexpression of a constitutively active DRP1-S616D mutant dramatically increases 
pluripotency markers, such as TRA-1–60, OCT4, and REX1 itself.
As in cancer cells, mitochondrial fusion seems to work in opposition to fission by driving 
differentiation and decreasing cellular proliferation. For example, the differentiation of 
human iPSCs into functional neurons requires MFN2 function (Fang et al., 2016). 
Knockdown of MFN2 reduces OXPHOS activity and inhibits dendrite and synapse 
formation, whereas overexpression of MFN2 enhances dendritic length, synaptophysin 
expression, and ATP production. Depending on the cellular context, loss of MFN2 (Mourier 
et al., 2015), of both MFN1 and MFN2, or of OPA1 (Chen et al., 2005) results in severe 
respiratory chain function, which is likely to be critical for cell differentiation.
Despite the plethora of evidence demonstrating the importance of DRP1 and mitochondrial 
fission and fragmentation in establishing and maintaining pluripotency, cell type differences 
exist and suggest that the relationship of mitochondrial dynamics to metabolism and cell 
identity is not straightforward. Genetic studies in the mouse brain suggest that mitochondrial 
fusion, rather than fission, may play a role in promoting self-renewal of neural stem cells 
(NSCs) of the cortex (Khacho et al., 2016). In contrast to embryonic and hematopoietic stem 
cells, which contain fragmented and immature mitochondria, neural stem cells have 
relatively abundant tubular mitochondria. These cells progress to form committed 
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progenitors, which have fragmented mitochondria. The committed progenitors then 
differentiate into post-mitotic neurons, which have elongated mitochondria. The NSCs 
therefore go through at least two structural transitions on their way to forming terminally 
differentiated neurons. When the mitochondrial fusion proteins MFN1 and MFN2 are 
removed from NSCs, they show mitochondrial fragmentation, increased tendency to 
differentiate, and reduced capacity for self-renewal (Khacho et al., 2016). Similar results 
were obtained for depletion of OPA1. Maintenance of elongated mitochondria therefore 
seems important for self-renewal of these neural stem cells. Interestingly, despite the 
differences in mitochondrial morphology, the metabolic requirements for neural stem cell 
pluripotency remained consistent with that of ESCs. Namely, the NSCs rely on aerobic 
glycolysis and progressively shift towards cellular respiration during cell fate commitment 
and differentiation. NSCs express high levels of UCP2 (Uncoupling protein 2) (Khacho et 
al., 2016), consistent with the high expression of UCP2 in human iPSCs and ESCs, where it 
inhibits mitochondrial glucose oxidation (Zhang et al., 2011). Biochemical analysis of 
recombinant UCP2 indicates that it functions as a metabolite transporter to export TCA 
cycle intermediates from the mitochondria (Vozza et al., 2014), and thus may suppress 
mitochondrial oxidation of glucose even in the presence of oxygen and functional 
mitochondrial respiration complexes. Therefore, in neural stem cells, aerobic glycolysis is 
still critical for maintaining pluripotency and replicative function, but mitochondria are 
maintained in elongated form as opposed to the fragmented form found in ESCs. Based on 
the divergent results from NSCs versus ESCs, it seems that the type of mitochondrial profile 
associated with stem cells is highly context dependent, as is the biological effect of 
inhibiting either mitochondrial fusion or fission. Clearly, there are still large gaps in our 
understanding of how mitochondrial dynamics and morphology intersect with metabolism 
and cell identity. Nevertheless, it is becoming clear that mitochondrial dynamics plays an 
important role in controlling stem cell metabolism, which is critical in determining the 
ability of these cells to self-renew or differentiate.
An interesting parallel to the NSCs may exist in the Drosophila egg chamber (Mitra et al., 
2012), where mitochondrial dynamics has been shown to control the differentiation of 
follicle cells. Expression of dominant-negative DRP1 in follicle cells causes their hyper-
proliferation, instead of differentiation. Conversely, inhibition of MARF-1 (a mitofusin 
ortholog) induced premature induction of differentiation markers. These effects correlate 
with the levels of cyclin E, suggesting that mitochondrial dynamics may affect cell 
differentiation by regulating cell cycle exit.
The observations with NSCs noted above suggest that different states of stem cells can have 
distinct mitochondrial and metabolic profiles. It is worth noting that pluripotent stem cells 
may also belong to two distinct states of pluripotency. Naive pluripotent stem cells are 
derived from the inner cell mass of preimplantation embryos, whereas primed pluripotent 
stem cells are derived from post-implantation embryos and represent a more mature state 
(Nichols and Smith, 2009; Weinberger et al., 2016). Among their differences in cellular 
properties, there is evidence that naive versus primed pluripotent stem cells are 
metabolically distinct (Zhou et al., 2012), pointing towards the complexity in understanding 
the metabolism of stem cells.
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Adding to the complexity, one group found that knockdown of DRP1 did not affect the 
reprogramming of MEFs into iPSCs (Wang et al., 2014). Surprisingly, even though 
fibroblasts depleted of DRP1 have very elongated mitochondria, the derived iPSCs have 
fragmented mitochondrial typical of iPSCs, raising the possibility that DRP1 is not involved 
in structural remodeling of mitochondria during this process. The DRP1-deficient iPSCs also 
showed reduced tendency to differentiate into neuroepithelium, consistent with the situation 
in neural stem cells (Khacho et al., 2016). Further testing will be required to understand the 
discrepancies among the studies regarding reprogramming of MEFs to iPSCs.
The role of mitochondrial dynamics in signaling differentiation
During the transition of neural stem cells to committed progenitor cells, the appearance of 
fragmented mitochondria is associated with increased ROS (Khacho et al., 2016). 
Experimental depletion of MFN1 and MFN2 or of OPA1 results in an increase in ROS that 
correlates with reduced NSC self-renewal and their increased differentiation to progenitor 
cells. The authors propose that this increase in ROS serves as an internal signal to drive cell 
differentiation. It is difficult to rule out that these effects are not due to mitochondrial 
dysfunction caused by depletion of mitochondrial fusion. However, the study showed that no 
gross reduction in respiratory chain function occurs.
A role for ROS in cell differentiation has been supported by studies in other systems. A 
particularly compelling case occurs in keratinocyte differentiation in the mouse epidermis 
(Hamanaka et al., 2013). Deletion of mitochondrial transcription factor A (TFAM) from the 
epidermis results in excessive basal layer proliferation and defective keratinocyte 
differentiation and hair development. Because TFAM is essential for maintenance of 
mitochondrial DNA, such cells cannot assemble functional respiratory chain complexes and 
have a severe bioenergetic defect. They also lack the ROS that is normally generated from 
endogenous respiration. Importantly, application of exogenous hydrogen peroxide caused 
restoration of differentiation markers to primary keratinocytes lacking TFAM, arguing that it 
is ROS, and not cellular ATP generation, that is essential for differentiation. A signaling 
function for ROS has been implicated to several other cell differentiation systems, including 
adipocytes, hematopoietic cells, neurons, and glial cells (Owusu-Ansah and Banerjee, 2009; 
Smith et al., 2000; Tormos et al., 2011; Tsatmali et al., 2005).
In addition to ROS, calcium signaling may also be affected by mitochondrial dynamics 
during cell differentiation. Mitochondrial fusion has been shown to be important for 
differentiation of mouse cardiomyocytes (Kasahara et al., 2013). Mice with MFN1 and 
MFN2 deletions in cardiomyocytes have hypoplastic hearts during embryonic development, 
and gene expression analysis shows reduced levels of markers for cardiac differentiation and 
proliferation. The differentiation of mouse ESCs into cardiomyocytes was found to require 
MFN2 and OPA1. In their absence, calcium entry, Notch and calcineurin signaling, known 
to inhibit cardiomyocyte differentiation, were hyperactive (Kasahara et al., 2013). A role of 
MFN2 in regulating intracellular calcium has also been reported for hematopoietic stems 
cells of the lymphoid lineage (Luchsinger et al., 2016).
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Perspectives
Recent studies provide persuasive evidence that mitochondrial dynamics plays an important 
role in regulating the unique metabolism of cancer cells and their ability to rapidly 
proliferate. Moreover, there are striking parallels between the metabolism of cancer cells and 
pluripotential stem cells. Mitochondrial dynamics appears to regulate the glycolytic 
metabolism of stem cells and their tendency towards self-renewal versus differentiation.
Looking ahead, there are several issues that need clarification. First, most of the cancer cell 
studies have focused on how mitochondrial dynamics affects cell proliferation, and it will be 
important to test whether the metabolic insights from stem cell studies also apply to tumor 
cells. Related to this issue, it is unclear whether the effects of mitochondrial fission on tumor 
cell proliferation arise from a change in metabolism or another cellular process. Second, 
there is not a simple relationship between mitochondrial morphology and metabolism. There 
is often an assumption that glycolytic cells have fragmented mitochondria, and that 
OXPHOS-intensive cells have elongated mitochondria. However, the discrepancies in 
mitochondrial profiles between glycolytic ESCs and neuronal stem cells suggest that this 
idea is an oversimplification. We will need additional studies to better understand the 
molecular mechanisms linking mitochondrial dynamics to cell metabolism. Third, it will be 
important to understand whether the effects of mitochondrial dynamics are cell-type-
specific. Because changes in mitochondrial dynamics can directly or indirectly impact 
multiple processes--including metabolism, ROS signaling, and calcium signaling--the 
outcome may be critically dependent on cell type. Finally, once the interconnections 
between mitochondrial dynamics, cell metabolism, and proliferation, and differentiation are 
better understood, we will hopefully be able to harness this information to devise therapies 
for tumorigenesis and to modulate stem cell function.
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Figure 1. Regulation of mitochondrial fission and its role in cancer and stem cells
The fission of mitochondria begins with an interaction with the endoplasmic reticulum, 
which causes initial constriction of the mitochondrial tubule. DRP1, recruited by one of 
several DRP1 receptors, assembles on the mitochondrial surface and causes further 
constriction. The final stage of membrane scission requires DYN2. The activity of DRP1 is 
regulated by molecules that control the phosphorylation of DRP1 at two serine residues, 
which have opposing effects. The level of mitochondrial fission has significant effects on 
tumor and stem cell phenotypes.
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Figure 2. Mitochondrial dynamics during the cell cycle
The two signature features of mitochondrial structure during the cell cycle are the 
hyperfused network at G1-S and the extensively fragmented state at mitosis. The hyperfused 
network at G1-S is associated with increased ATP and high cyclin E levels. The fragmented 
state during mitosis facilitates equitable distribution of mitochondria to daughter cells. 
Fragmentation is driven by phosphorylation of DRP1 by CDK1/cyclin B, causing the 
activation of DRP1 and mitochondrial fission. Aurora A works upstream to activate CDK1/
cyclin B.
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Figure 3. Metabolic rewiring in normal versus cancer cells
Differentiated cells typically rely heavily on the OXPHOS activity of mitochondria. In 
contrast, many cancer cells show the Warburg effect, characterized by reliance on aerobic 
glycolysis and reduced emphasis on OXPHOS. Glycolysis, though less energy efficient than 
OXPHOS, generates metabolic intermediates that provide building blocks for synthesis of 
amino acids (AAs), fatty acids (FAs), and nucleotides (NTPs).
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Figure 4. Mitochondrial and metabolic profiles of stem cells versus differentiated cells
ESCs have less reliance on mitochondrial metabolism, and this is reflected in the 
ultrastructure of their mitochondria. Similar differences exist when somatic cells are 
reprogrammed into iPSCs. As noted in the main text, these generalizations for mitochondrial 
structure in stem cells do not apply to neural stem cells. ROS and calcium are two regulators 
of differentiation that are regulated by mitochondrial function.
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